Angle Regulatory News (AGL)



Regulatory News for Angle (AGL)


Share Price: 60.75Bid: 58.50Ask: 60.00Change: 1.50 (+2.53%)Riser - Angle
Spread: 1.50Spread as %: 2.56%Open: 56.50High: 59.90Low: 56.575Yesterday’s Close: 59.25





Portfolio Company Announces Strengthening Sales

Mon, 24th Oct 2011 07:00

RNS Number : 6687Q
Angle PLC
24 October 2011
 

?

For immediate release

24 October 2011

 

ANGLE plc

 

("ANGLE" or the "Company")

 

PORTFOLIO COMPANY GEOMERICS ANNOUNCES STRENGTHENING SALES

 

 

ANGLE plc, which focuses on the commercialisation of technology, is pleased to announce that its 33% owned portfolio company Geomerics, which specialises in computer games middleware, has made significant progress on a number of fronts.

 

Sales continue to grow at an encouraging rate. Geomerics' Enlighten technology is now being employed in 18 titles worldwide and is currently in evaluation and under consideration for many more. Among these titles are two of the most hotly anticipated games of 2011. Battlefield 3, from EA DICE, is released on 28th October. It is considered a challenger to Call of Duty's market dominance. The game has been backed by a $100m marketing campaign and has received high praise and multiple awards for the quality of its graphics, of which the lighting is driven by Geomerics' Enlighten engine. Battlefield 3 is followed by the release of Need for Speed: The Run on 18th November. This is the next game in one of the most successful franchises of all time and is built on the same Enlighten technology as Battlefield 3.

 

Geomerics is also delighted that it has secured its first deal inside Korea, which will see Enlighten used in multiple titles. This opens up a whole new market for Enlighten and, on the back of sales in Japan, demonstrates that Geomerics is on its way to establishing a strong base in the Asian market.

 

Geomerics' participation in Epic Games' prestigious Unreal Engine 3 Integrated Partners Programme continues to go well and is yielding a range of new sales opportunities.    

 

Finally, Geomerics has been awarded new grant funding to research applications of its technology on mobile devices. Geomerics will receive €470,000 over the next three years as part of a €2.8 million EU-funded project researching the next generation of graphics technology for mobile platforms.

 

 

 

Chris Doran, Founder of Geomerics, commented:

"At Geomerics we have tracked the rise in performance of mobile platforms very closely. It is clear that they are fast approaching console performance, and at the high end will overtake this in 2012. We are very excited about the prospect of taking our console technology to mobile platforms, and to contributing to joint R&D on the future direction of graphics technology for mobile devices."

 

 

Andrew Newland, Chief Executive of ANGLE commented:

"We are very pleased with the Geomerics' continued strong progress and look forward to the positive market impact when Battlefield 3 launches at the end of this week."

 

 

 

 

 

For further information:

ANGLE plc

01483 685830

Andrew Newland, Chief Executive

Ian Griffiths, Finance Director

 


Collins Stewart Europe Limited

Matt Goode

 

0207 523 8325

Buchanan

Lisa Baderoon

 

0207 466 5000

Scott Harris

Stephen Scott, Harry Dee

 

0207 653 0030

 

 

About Geomerics  www.geomerics.com 

 

Geomerics is an innovation-led company developing cutting-edge graphics technology for the games industry. Based in Cambridge, UK, Geomerics has built a team that combines world-class management and games industry experience with some of the UK's leading researchers. Geomerics launched its groundbreaking Enlighten technology in 2009. Enlighten redefines how designers use and control lighting within a game.

 

Geomerics partners with many of the leading companies in the games industry and is currently working with developers around the world on AAA titles for release in 2011 and 2012. The first titles incorporating Enlighten include the highly anticipated 'Battlefield 3' and 'Need for Speed: The Run'.

 

For more details about Geomerics research into mobile platforms, visit www.lpgpu.org 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRBDGLBDBGBX


Related Shares: Angle (AGL).




DateSourceHeadlineCategory
13-May-13 07:00RNSPARSORTIX CELL HARVESTINGCompany Announcement - General
07-May-13 07:00RNSParsortix Regulatory Approval UpdateCompany Announcement - General
28-Feb-13 07:00RNSParsortix Research Product LaunchCompany Announcement - General
15-Feb-13 10:56RNSDirector's share transferDirectors' Dealings
31-Jan-13 07:01RNSFundraising and Director's DealingsCompany Announcement - General
31-Jan-13 07:00RNSInterim ResultsResults and Trading Reports
16-Jan-13 07:00RNSNotification of Interim Results and WebcastCompany Announcement - General
15-Jan-13 07:00RNSAcolyte Biomedica SettlementCompany Announcement - General
14-Jan-13 07:00RNSParsortix Cell RecoveryCompany Announcement - General
07-Jan-13 07:00RNSAppointment of NEDExecutive Changes
18-Dec-12 07:00RNSParsortix Released to Research PartnersCompany Announcement - General
10-Dec-12 07:00RNSBUSINESS UPDATECompany Announcement - General
18-Oct-12 07:00RNSAppointment of Scientific AdvisersCompany Announcement - General
17-Oct-12 15:45RNSHolding(s) in the CompanyHolding(s) in Company
11-Oct-12 15:39RNSResult of 2012 Annual General MeetingResults and Trading Reports
03-Sep-12 07:00RNSIncreased FundraisingCompany Announcement - General
01-Aug-12 07:00RNSIncreased FundraisingCompany Announcement - General
26-Jul-12 07:01RNSFundraisingCompany Announcement - General
26-Jul-12 07:00RNSPreliminary ResultsResults and Trading Reports
24-Jul-12 07:00RNSNotice of Preliminary Results and Conference CallCompany Announcement - General
27-Jun-12 07:00RNSOffer Unconditional for Novocellus' Partner OrigioCompany Announcement - General
07-Jun-12 07:00RNSUpdate Re Novocellus' Partner ORIGIO A/SCompany Announcement - General
16-May-12 07:00RNSGeomerics Milestone PaymentCompany Announcement - General
30-Apr-12 07:00RNSParsortix Design BreakthroughCompany Announcement - General
26-Apr-12 07:00RNSLaunches New Corporate WebsiteCompany Announcement - General
23-Apr-12 07:00RNSParsortix Update for Breast CancerCompany Announcement - General
17-Apr-12 07:00RNSParsortix Validation for Ovarian CancerCompany Announcement - General
11-Apr-12 07:00RNSNovocellus Embryosure® Trial StartedCompany Announcement - General
15-Mar-12 07:00RNSParsortix Validation for Colon CancerCompany Announcement - General
07-Mar-12 08:00RNSHolding(s) in the CompanyHolding(s) in Company


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.